XML 22 R13.htm IDEA: XBRL DOCUMENT

Loss per Share

9 Months Ended

Sep. 30, 2022

7.Loss per Share

Basic and diluted loss per share was the same for each period presented as the inclusion of all common share equivalents would have been anti-dilutive. Anti-dilutive equivalent common shares were as follows:


	Nine months ended	Nine months ended
	September 30,	September 30,
	2022	2021
Outstanding options to purchase common shares	25,140,262	25,287,670
Outstanding RSUs	5,021,783	56,224
Outstanding shares under ESPP	34,116	—
Outstanding warrants	36,078,620	36,078,620
Outstanding Special Shares and options to purchase Special Shares	136,239,964	136,239,964
Total anti-dilutive common equivalent shares	202,514,745	197,662,478